Page 4 of 16
Uses of BTX therapy in the patient with cerebral palsy include the following:
- As an agent to decrease deformity in a growing child by modifying dynamic forces
- To modify the dynamic phase of deformity from ages 1 to 7 years
- To potentially improve muscle growth
- To protect released or transferred muscles during the immediate postoperative period
- To improve function during the acquisition phase of motor development
- To potentially improve motor control by decreasing focal spasticity
- To control postoperative pain